| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
108,000,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
5,721,727 |
Avg
Vol: |
2,654,246 |
| 52
Week Range: |
$73.89 - $73.89 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Leff Jonathan S |
Director |
– • – |
2011-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
18,718 |
79,726 |
|
- |
|
| Leff Jonathan S |
Director |
– • – |
2011-06-07 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,468,735) |
16,481 |
|
- |
|
| Kabakoff David S |
Director |
– • – |
2011-06-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,000 |
35,002 |
|
- |
|
| Kabakoff David S |
Director |
– • – |
2011-06-02 |
4 |
S |
$36.41 |
$72,819 |
D/D |
(2,000) |
50,002 |
|
- |
|
| Porter Steven Bryant |
Chief Medical Officer |
• – – |
2011-06-01 |
4 |
S |
$37.01 |
$119,379 |
D/D |
(3,226) |
56,158 |
|
- |
|
| Bradford Williamson Z III |
SVP-Clinical Science |
• – – |
2011-06-01 |
4 |
AS |
$36.79 |
$220,724 |
D/D |
(6,000) |
65,922 |
|
- |
|
| Bradford Williamson Z III |
SVP-Clinical Science |
• – – |
2011-06-01 |
4 |
OE |
$12.74 |
$76,440 |
D/D |
6,000 |
71,922 |
|
- |
|
| Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
• – – |
2011-06-01 |
4 |
S |
$36.50 |
$116,301 |
D/D |
(3,186) |
56,158 |
|
- |
|
| Cohen Alan Howard |
SVP, Medical Affairs |
• – – |
2011-05-31 |
4 |
S |
$37.16 |
$1,344,762 |
D/D |
(36,189) |
27,000 |
|
- |
|
| Cohen Alan Howard |
SVP, Medical Affairs |
• – – |
2011-05-31 |
4 |
OE |
$11.81 |
$398,576 |
D/D |
33,749 |
63,189 |
|
- |
|
| Hodgman John |
SVP-Finance & CFO |
• – – |
2011-05-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
62,214 |
|
- |
|
| Simon Howard Allan |
SVP-Human Resources |
• – – |
2011-05-18 |
4 |
S |
$38.78 |
$4,252,602 |
D/D |
(109,656) |
40,362 |
|
- |
|
| Simon Howard Allan |
SVP-Human Resources |
• – – |
2011-05-18 |
4 |
OE |
$12.74 |
$1,584,587 |
D/D |
106,223 |
150,018 |
|
- |
|
| Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
• – – |
2011-05-18 |
4 |
AS |
$37.22 |
$67,822 |
D/D |
(1,822) |
59,344 |
|
- |
|
| Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
• – – |
2011-05-18 |
4 |
OE |
$15.34 |
$27,949 |
D/D |
1,822 |
61,166 |
|
- |
|
| Bradford Williamson Z III |
SVP-Clinical Science |
• – – |
2011-05-18 |
4 |
AS |
$37.17 |
$223,018 |
D/D |
(6,000) |
65,922 |
|
- |
|
| Bradford Williamson Z III |
SVP-Clinical Science |
• – – |
2011-05-18 |
4 |
OE |
$12.74 |
$76,440 |
D/D |
6,000 |
71,922 |
|
- |
|
| Porter Steven Bryant |
Chief Medical Officer |
• – – |
2011-05-18 |
4 |
AS |
$37.05 |
$67,095 |
D/D |
(1,811) |
59,384 |
|
- |
|
| Porter Steven Bryant |
Chief Medical Officer |
• – – |
2011-05-18 |
4 |
OE |
$15.34 |
$27,781 |
D/D |
1,811 |
61,195 |
|
- |
|
| Welch Daniel G |
Chairman, CEO and President |
• • – |
2011-05-18 |
4 |
AS |
$37.22 |
$772,323 |
D/D |
(20,750) |
259,280 |
|
- |
|
| Di Nepi Giacomo |
SVP, Managing Director, Europe |
• – – |
2011-05-17 |
4 |
S |
$37.75 |
$1,507,817 |
D/D |
(39,939) |
24,560 |
|
- |
|
| Di Nepi Giacomo |
SVP, Managing Director, Europe |
• – – |
2011-05-17 |
4 |
OE |
$13.56 |
$508,486 |
D/D |
37,499 |
64,499 |
|
- |
|
| Welch Daniel G |
Chairman, CEO and President |
• • – |
2011-05-16 |
4 |
AS |
$38.22 |
$133,961 |
D/D |
(3,505) |
280,030 |
|
- |
|
| Welch Daniel G |
Chairman, CEO and President |
• • – |
2011-05-16 |
4 |
D |
$38.00 |
$61,104 |
D/D |
(1,608) |
283,535 |
|
- |
|
| Simon Howard Allan |
SVP-Human Resources |
• – – |
2011-05-16 |
4 |
D |
$37.78 |
$13,374 |
D/D |
(354) |
43,795 |
|
- |
|
772 Records found
|
|
Page 10 of 31 |
|
|
